Polygen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for POLYGEN PHARMS, and what generic and branded alternatives to POLYGEN PHARMS drugs are available?
POLYGEN PHARMS has four approved drugs.
Summary for Polygen Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Polygen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polygen Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 210587-001 | Dec 11, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Polygen Pharms | DARIFENACIN HYDROBROMIDE | darifenacin hydrobromide | TABLET, EXTENDED RELEASE;ORAL | 211045-001 | Jan 6, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Polygen Pharms | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 213351-002 | Jul 17, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Polygen Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 210587-002 | Dec 11, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
